Overall rank by patents
#24,011
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Boehringer ranks #24,011 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R24011 · Foreign Corporation #24,011 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: BLUE Tomato, Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Boehringer Ingelheim… · this assignee
36 score
3D Lighting Innovati… · lowest
7 score
What this shows Boehringer's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Boehringer Ingelheim Pharma Gmbh & Co. KG is a focused PatentsView assignee: 9 CPC subclasses with 45.5% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Boehringer sits between BLUE Tomato, Llc and Bormioli Pharma S.p.a..
Boehringer Ingelheim Pharma Gmbh & Co. KG shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BLUE TOMATO, LLC
11 patents
BLUEDOT INNOVATION PTY LTD.
11 patents
BNL EUROLENS
11 patents
BOBST FIRENZE S.R.L
11 patents
BOEWE SYSTEC GMBH
11 patents
BOOLABOX, INC.
11 patents
BORESKOV INSTITUTE OF CATALYSIS
11 patents
BORMIOLI PHARMA S.P.A.
11 patents
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
11 patents
What this shows Boehringer holds 11 patents at rank #23,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,974 in granted patent volume.
Other assignees with the most granted patents in Boehringer's primary technology class.
Boehringer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 54.5% |
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
Top 9 of 9 technology areas
Overall rank by patents
#24,011
of 50,000 tracked assignees
36.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.